These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10380824)

  • 1. Stability and immunoreactivity of the monoclonal anticytokeratin antibody TS1 after different degrees of iodination.
    Johansson A; Sandström P; Ullén A; Erlandsson A; Sundström B; Ahlström KR; Johansson L; Hietala SO; Stigbrand T
    Acta Oncol; 1999; 38(3):329-34. PubMed ID: 10380824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental radioimmunotargeting combining nonlabeled, iodine-125-labeled, and anti-idiotypic anticytokeratin monoclonal antibodies: a dosimetric evaluation.
    Rossi Norrlund R; Ullén A; Sandström P; Holback D; Johansson L; Stigbrand T; Hietala SO; Riklund Ahlström K
    Cancer; 1997 Dec; 80(12 Suppl):2689-98. PubMed ID: 9406726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetry of fractionated experimental radioimmunotargeting with idiotypic and anti-idiotypic anticytokeratin antibodies.
    Rossi Norrlund R; Ullén A; Sandström P; Holback D; Johansson L; Stigbrand T; Hietala SO; Riklund Ahlström K
    Cancer; 1997 Dec; 80(12 Suppl):2681-8. PubMed ID: 9406725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of anticytokeratin monoclonal anti-idiotypic antibodies to improve tumor:nontumor ratio in experimental radioimmunolocalization.
    Ullén A; Sandström P; Ahlström KR; Sundström B; Nilsson B; Arlestig L; Stigbrand T
    Cancer Res; 1995 Dec; 55(23 Suppl):5868s-5873s. PubMed ID: 7493362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoscintigraphy with a novel monoclonal antiprostate antibody (E4): an experimental study in nude mice.
    Rydh A; Riklund Ahlström K; Widmark A; Johansson L; Nilsson S; Bergh A; Damber JE; Stigbrand T; Hietala SO
    Cancer; 1997 Dec; 80(12 Suppl):2398-403. PubMed ID: 9406689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of external beam radiotherapy and experimental radioimmunotargeting with a monoclonal anticytokeratin antibody.
    Johansson A; Eriksson D; Ullén A; Löfroth PO; Johansson L; Riklund-Ahlström K; Stigbrand T
    Cancer; 2002 Feb; 94(4 Suppl):1314-9. PubMed ID: 11877762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of growth of HeLa cell tumours in nude mice by 125I-labeled anticytokeratin and antiPLAP monoclonal antibodies.
    Riklund KE; Makiya R; Sundström B; Bäck O; Henriksson R; Hietala SO; Stigbrand T
    Anticancer Res; 1991; 11(2):555-60. PubMed ID: 1712175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetry of fractionated administration of 125I-labeled antibody at experimental radioimmunotargeting.
    Ullén A; Sandström P; Rossi Norrlund R; Rathsman S; Johansson L; Riklund Ahlström K; Hietala SO; Stigbrand T
    Cancer; 1997 Dec; 80(12 Suppl):2510-8. PubMed ID: 9406704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.
    Lahorte CM; Bacher K; Burvenich I; Coene ED; Cuvelier C; De Potter C; Thierens H; Van de Wiele C; Dierckx RA; Slegers G
    J Nucl Med; 2004 Jun; 45(6):1065-73. PubMed ID: 15181142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN.
    Visser GW; Klok RP; Gebbinck JW; ter Linden T; van Dongen GA; Molthoff CF
    J Nucl Med; 2001 Mar; 42(3):509-19. PubMed ID: 11337531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental studies for immunoscintigraphy of adenocarcinoma of the prostate with 125I-labeled monoclonal antibody to gamma-seminoprotein].
    Fujino A; Suyama K; Shidara T; Ao T; Ishibashi A; Koshiba K
    Nihon Hinyokika Gakkai Zasshi; 1994 Feb; 85(2):271-80. PubMed ID: 8121109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
    DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A
    Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement by affinity chromatography on antiidiotypic monoclonal antibodies (MAbs) of immunoreactivity and in vivo targeting of radiolabelled anti-HMW-MAA MAb TP61.5 in nude mice bearing human melanoma lesions.
    Temponi M; Fawwaz RA; Kekish U; Wang TS; Ferrone S
    Int J Cancer; 1991 Oct; 49(4):624-30. PubMed ID: 1917164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts.
    Buchsbaum DJ; Lawrence TS; Roberson PL; Heidorn DB; Ten Haken RK; Steplewski Z
    Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):629-38. PubMed ID: 8454481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct technetium-99m labeling of three anticancer monoclonal antibodies: stability, pharmacokinetics and imaging.
    Gooden CS; Snook DE; Maraveyas A; Rowlinson-Busza G; Peters AM; Epenetos AA
    J Nucl Med; 1995 May; 36(5):842-9. PubMed ID: 7738662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of complexed anticytokeratin 8 scFv TS1-218 to HeLa HEp-2 multicellular tumor spheroids and experimental tumors.
    Jafari R; Holm P; Sandegren J; Stigbrand T; Sundström BE
    Cancer Biother Radiopharm; 2010 Aug; 25(4):455-63. PubMed ID: 20707717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radio-immunolocalization in nude mice using anticytokeratin monoclonal antibodies.
    Sundström B; Johansson B; Hietala SO; Stigbrand T
    Tumour Biol; 1990; 11(3):158-66. PubMed ID: 1693011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific conjugation of a radioiodinated phenethylamine derivative to a monoclonal antibody results in increased radioactivity localization in tumor.
    Kurth M; Pèlegrin A; Rose K; Offord RE; Pochon S; Mach JP; Buchegger F
    J Med Chem; 1993 Apr; 36(9):1255-61. PubMed ID: 8487262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of radiolysis of monoclonal antibody during labeling.
    Chakrabarti MC; Le N; Paik CH; De Graff WG; Carrasquillo JA
    J Nucl Med; 1996 Aug; 37(8):1384-8. PubMed ID: 8708780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.